Search the Newsreel

Sotera Health (SHC): Sessa Capital discloses 27M-share, 9.5% ownership position

Sessa Capital IM, L.P. and John Petry have disclosed a beneficial ownership of 27,050,000 shares of Sotera Health Co (SHC) common stock, representing a 9.5% stake. This information was reported on an amended Schedule 13G filing, indicating shared voting and dispositive power over these …

Sotera Health (SHC): Sculptor Capital discloses 24M-share, 8.41% ownership stake

Sculptor Capital LP and its related entities have reported a beneficial ownership stake of 8.41% in Sotera Health Company (SHC), totaling 24,000,000 common shares. This disclosure, made via an amended Schedule 13G filing, indicates shared voting and dispositive power over these shares. The ownership …

Sotera Health announces resignation of director James C. Neary

Sotera Health (NASDAQ:SHC) announced the resignation of James C. Neary from its Board of Directors, effective Thursday. The company clarified that his resignation was not due to any disagreements regarding its operations. This news follows Sotera Health's strong second-quarter financial results, where it surpassed …

Shaftesbury Capital sets exchange rate for interim dividend

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?

Sotera Health Company (SHC) has gained 11.3% over the last six months, slightly underperforming the S&P 500. Analysts are not recommending SHC due to slow organic growth, limited distribution channels for a small company in a scale-dependent industry, and breakeven free cash flow constraining …

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Jason Peterson Executive Chairman - Michael Petras Chief Executive Officer - Alton Shader Chief Financial Officer - Jonathan Lyons Full Conference Call …

President of Sterigenics U.S. Of Sotera Health Sold 37% Of Their Shares

The President of Sterigenics U.S., Michael Rutz, recently sold 37% of his shares in Sotera Health Company (NASDAQ:SHC) for approximately US$2.8 million. This sale follows another significant insider sale by the Executive Chairman of the Board, Michael Petras, worth US$12 million over the past …

Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions

Sotera Health reported strong Q2 2026 results with broad-based growth across its business units, exceeding analyst estimates for revenue, EPS, and EBITDA, and subsequently raising its full-year guidance. The article highlights five key analyst questions from the earnings call, focusing on drivers of Nelson …

Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares

Shaftesbury Capital (LON:SHC) Given New GBX 195 Price Target at Deutsche Bank Aktiengesellschaft

Shaftesbury Capital sets exchange rate for interim dividend By Investing.com

Shaftesbury Capital sets tax and FX terms for 2026 interim dividend

REG - Shaftesbury Capital - 2026 Interim Dividend - Exchange Rate

Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

Sotera Health insider Michael Rutz sold 150,000 shares of the company's stock for $2,826,000.00, reducing his position by nearly 31%. This sale follows strong quarterly results where the company beat EPS estimates and saw revenue increase by 9.2% year-over-year. Analysts have maintained a "Moderate …

Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins

US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …

Berenberg Bank Forecasts Strong Price Appreciation for Shaftesbury Capital (LON:SHC) Stock

Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?

Sotera Health (SHC) has gained renewed attention following its Q2 2026 earnings, reporting increased revenue and net income. The stock has shown strong recent performance, with a 22.23% 90-day return and a 35.00% one-year return. Analysts have a consensus price target of $20.22, suggesting …

Sotera Health (SHC) Stock Trails Profit Surge As Legal Risks Linger

Sotera Health (SHC) recently reported strong Q2 2026 earnings, with significant increases in revenue and net income, yet its stock price barely moved due to lingering legal risks, heavy capital spending, and past insider selling. The company's operating performance, particularly in its sterilization and …

Piper Sandler Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $25

Piper Sandler has reiterated its "Buy" rating for Sotera Health Company (SHC.US) and increased the target price to $25. This indicates a positive outlook from the analyst firm regarding the company's future performance.

Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed

Sotera Health Company's Q2 2026 results, released on August 6, showed revenue rising to US$321.38 million and net income to US$53.64 million, with earnings per share from continuing operations increasing to US$0.19 from US$0.03 a year earlier. Management's decision to raise full-year guidance after …

GUIDANCE: (SHC) Sotera Health Expects Full Year 2026 Revenue Range $1.24B - $1.25B, Vs. FactSet Est of $1.24B

Sotera Health (SHC) has provided its revenue guidance for the full year 2026, expecting it to fall within the range of $1.24 billion to $1.25 billion. This forecast aligns closely with FactSet's estimated revenue of $1.24 billion for the same period. The guidance offers …

Sotera Health Company Stock 12‑Month Price Target Raised to $21.44, Implies 19% Upside

Sotera Health Company (SHC) has seen its average 12-month price target raised from $20.44 to $21.44 by analysts, implying a 19% potential upside based on its closing price on August 5th. The consensus rating among 10 analysts remains a "Buy," with 8 recommending Buy …

Sotera Health Co 2026: Revenue $321.38M, EPS $0.19— 10-Q Summary

Sotera Health Co (SHC) reported strong second-quarter 2026 results, with revenue reaching $321.38 million and diluted EPS of $0.19. The company saw significant year-over-year improvement across all key financial metrics, driven by higher service pricing and a favorable product mix. Despite ongoing expenses related …

Is Sotera Health Co (SHC) Overvalued After Q2 Earnings Beat? EPS at $0.19 vs. Est. $0.17; Revenue at $321.4M

Will Sotera Health's (SHC) Sharp Profit Rebound and Higher EPS Rewrite Its Turnaround Narrative?

Sotera Health (SHC) reported a significant profit rebound in Q2 2026, with net income rising to US$53.64 million and EPS to US$0.19, shifting from a net loss in the first half of the year. This turnaround in profitability is a key catalyst for its …

Sotera Health (NASDAQ:SHC) Beats Q2 Estimates and Raises Guidance, But Shares Slip

Sotera Health (SHC) exceeded analyst expectations for its second-quarter earnings and revenue, reporting $0.26 adjusted EPS and $321.4 million in net revenues. The company also raised its full-year guidance for net revenues and adjusted EPS, and improved its net leverage to 3.0 times. Despite …

Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) reported strong Q2 2026 earnings, beating analyst estimates for both EPS ($0.26 vs. $0.24) and revenue ($321.38 million vs. $310.27 million). This marks the fourth consecutive quarter the company has surpassed both earnings and revenue expectations. Despite this positive performance, …

Sotera Health Company (NASDAQ:SHC) Surprises With Strong Q2 CY2026

Sotera Health (NASDAQ:SHC) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS expectations with sales up 9.2% year-on-year to $321.4 million. The company slightly increased its full-year revenue and Adjusted EPS guidance, demonstrating focused execution across its business units. Despite a mediocre 6.7% …

Earnings Flash (SHC) Sotera Health Company Reports Q2 Revenue $321.4M, vs. FactSet Est of $309.7M

Sotera Health Company (SHC) announced its Q2 revenue of $321.4 million, surpassing FactSet's estimate of $309.7 million. The company also reported Q2 adjusted EPS of $0.26 per share, exceeding the FactSet estimate of $0.24 per share. Following these results, Sotera Health has lifted the …

Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health (SHC) reported strong Q2 2026 earnings, with revenue up 9.2% year-over-year to $321.38 million and EPS at $0.26. The company surpassed Zacks Consensus Estimates for both revenue and EPS, showing a surprise of +3.29% and +8.33% respectively. Key segment metrics for Sterigenics, …

Sotera Health Reports Strong Q2 2026 Results, Raises Full-Year Outlook

Sotera Health Co (SHC) Shares Surge 5.1% -- What GF Score of 77 Tells Investors

BlackRock, Inc. Adds to Sotera Health Co (SHC) Stake -- Shares S